Related Experiment Video

Updated: Apr 13, 2026

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

11.0K

Tumor microenvironment: a new treatment target for cancer

Ming-Ju Tsai1, Wei-An Chang2, Ming-Shyan Huang3

  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan ; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

ISRN Biochemistry
|May 5, 2015
PubMed

Insights

Cancer therapies face resistance due to tumor microenvironment factors. Understanding these interactions is crucial for developing new, effective anticancer treatments and overcoming drug resistance.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Cancer therapies often fail due to acquired drug resistance and disease relapse.
  • The tumor microenvironment (TME) significantly influences cancer progression, metastasis, and treatment resistance.
  • Key TME components include immune cells, stromal cells, and extracellular matrix, which interact dynamically with cancer cells.

Purpose of the Study:

  • To highlight the critical role of the tumor microenvironment in cancer progression and therapeutic resistance.
  • To discuss the limitations of current preclinical cancer models in replicating the human tumor microenvironment.
  • To emphasize the need for TME-targeted strategies in future cancer therapy development.

Main Methods:

  • Review of current literature on tumor microenvironment and cancer therapy.
  • Analysis of mechanisms by which TME components contribute to drug resistance.
  • Evaluation of existing preclinical models for their ability to mimic the TME.

Main Results:

  • The TME promotes cancer progression, epithelial-mesenchymal transition, angiogenesis, and metastasis.
  • Dysregulated immune responses within the TME are critical for treatment failure.
  • Current preclinical models inadequately simulate the complex TME, limiting translational success.

Conclusions:

  • The tumor microenvironment is a pivotal factor in cancer recurrence and drug resistance.
  • Future anticancer therapies must integrate TME-targeting strategies for improved efficacy.
  • Advancements in understanding the TME may facilitate the design of novel, successful cancer eradication treatments.

More Related Videos

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

12.2K
Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

2.6K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K